Ceapro

Ceapro Debt

Delisted

The Debt of Ceapro (CZO.V) as of Oct 31, 2026 is 2.25 M CAD. In the previous year, Debt was 2.62 M CAD — a change of -14.14% (lower).

Debt

2.25 MCAD

YoY

-14.14%

Last updated:

In 2023, Ceapro's total debt was 2.25 M CAD, a -14.14% change from the 2.62 M CAD total debt recorded in the previous year.

The Ceapro Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2016
2.53 M CAD
Jan 1, 2017
1.53 M CAD
Jan 1, 2018
635,500.00 CAD
Jan 1, 2019
3.29 M CAD
Jan 1, 2020
2.97 M CAD
Jan 1, 2021
2.65 M CAD
Jan 1, 2022
2.62 M CAD
Jan 1, 2023
2.25 M CAD
The Ceapro Debt history
YEARDebtYoY
2.25 MCAD-14.14%
2.62 MCAD-1.13%
2.65 MCAD-10.87%
2.97 MCAD-9.59%
3.29 MCAD+417.25%
635,500.00CAD-58.35%
1.53 MCAD-39.74%
2.53 MCAD-43.00%
4.44 MCAD+28.11%
3.47 MCAD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ceapro Stock analysis

What does Ceapro do? Ceapro Inc is an innovative biotechnology company based in Edmonton, Canada. The company was founded in 1997 and has since specialized in the development of natural, biological ingredients from plants. It is listed on the Toronto Stock Exchange and has become a key player in the field of natural-based medicine and cosmetics in recent years. Ceapro's business model is based on the research and production of active compounds from plant-based raw materials. The company employs gentle extraction methods that preserve the effectiveness of the ingredients and enable environmentally friendly production. Ceapro collaborates closely with research and industry to ensure the best possible effectiveness and applicability of its products. The company's products are divided into various segments tailored to the needs of customers. One important segment is medicine, where Ceapro focuses on the development of herbal remedies. The company has already developed some promising products in this area, which can be used, for example, for inflammation, pain, or diabetes. Another important segment of Ceapro is cosmetics, where the company researches and produces natural ingredients for skin and hair care. These products are known for their high effectiveness, tolerability, and environmental friendliness. One of the company's most famous products is Avenanthramide, an ingredient derived from oats that offers anti-aging and anti-inflammatory properties. Ceapro also places special emphasis on the development of digestive-aid ingredients that can be used in the food industry. The company relies on plant enzymes and compounds that help support and relieve the digestive system. The use of natural ingredients ensures high tolerability and usability. Over the course of its history, Ceapro Inc has already won numerous awards and prizes that confirm the high quality of its products and the company's innovative power. For example, the company has been repeatedly honored with the Alberta Venture Fast Growth 50 Award and also received the Environmental Stewardship Award from the Edmonton Chamber of Commerce. Ceapro is not only an innovative biotechnology company specializing in the research and production of plant-based ingredients but also an important player in the fields of medicine and cosmetics. The company employs gentle extraction methods and collaborates closely with research and industry to achieve the best possible effectiveness and applicability. The different products are divided into the segments of medicine, cosmetics, and food and are known for their high effectiveness, tolerability, and environmental friendliness. Ceapro is one of the most popular companies on Eulerpool.

Debt Details

Understanding Ceapro's Debt Structure

Ceapro's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Ceapro's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Ceapro’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Ceapro’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Ceapro stock

Debt of Ceapro is 2.25 M CAD in 2023.

Debt of Ceapro changed from 2.62 M CAD to 2.25 M CAD, representing a -14.14% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Ceapro since 2006 – with annual values, charts, and detailed analysis.

Debt's CAD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Ceapro historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ceapro

All Key Metrics — Ceapro